Semnur Pharmaceuticals, Inc. (SMNR)
0.4625
0.00 (0.00%)
USD |
OTCM |
Sep 24, 16:00
Semnur Pharmaceuticals Cash from Operations (TTM) : -10.49M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -10.49M |
| March 31, 2026 | -8.086M |
| December 31, 2025 | -5.814M |
| September 30, 2025 | -3.616M |
| June 30, 2025 | -4.533M |
| March 31, 2025 | -4.916M |
| December 31, 2024 | -4.891M |
| September 30, 2024 | -3.643M |
| Date | Value |
|---|---|
| June 30, 2024 | -0.7233M |
| March 31, 2024 | -0.7665M |
| December 31, 2023 | -0.6328M |
| September 30, 2023 | -0.6396M |
| June 30, 2023 | -0.6056M |
| March 31, 2023 | -0.6665M |
| December 31, 2022 | -0.4261M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Scilex Holding Co. | -17.27M |
| ANI Pharmaceuticals, Inc. | 189.47M |
| Corcept Therapeutics, Inc. | 109.70M |
| Veru, Inc. | -26.04M |
| Johnson & Johnson | 27.61B |